Acer Therapeutics Reports Q1 2023 Financial Results and
U.S. OLPRUVA™ launch progressing ahead of schedule with drug-in-channel now anticipated in mid-June 2023...
Source: globenewswire.com
Stay updated with breaking news from Event Reduction. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
U.S. OLPRUVA™ launch progressing ahead of schedule with drug-in-channel now anticipated in mid-June 2023...